• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外3D球体培养系统显示慢性淋巴细胞白血病在T细胞依赖性作用下持续增殖和存活。

In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival.

作者信息

Haselager Marco V, van Driel Bianca F, Perelaer Eduard, de Rooij Dennis, Lashgari Danial, Loos Remco, Kater Arnon P, Moerland Perry D, Eldering Eric

机构信息

Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Meibergdreef, The Netherlands.

Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands.

出版信息

Hemasphere. 2023 Aug 23;7(9):e938. doi: 10.1097/HS9.0000000000000938. eCollection 2023 Sep.

DOI:10.1097/HS9.0000000000000938
PMID:37637994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10448932/
Abstract

Chronic lymphocytic leukemia (CLL) cells are highly dependent on microenvironmental cells and signals. The lymph node (LN) is the critical site of in vivo CLL proliferation and development of resistance to both chemotherapy and targeted agents. We present a new model that incorporates key aspects of the CLL LN, which enables investigation of CLL cells in the context of a protective niche. We describe a three-dimensional (3D) in vitro culture system using ultra-low attachment plates to create spheroids of CLL cells derived from peripheral blood. Starting from CLL:T cell ratios as observed in LN samples, CLL activation was induced by either direct stimulation and/or indirectly via T cells. Compared with two-dimensional cultures, 3D cultures promoted CLL proliferation in a T cell-dependent manner, and enabled expansion for up to 7 weeks, including the formation of follicle-like structures after several weeks of culture. This model enables high-throughput drug screening, of which we describe response to Btk inhibition, venetoclax resistance, and T cell-mediated cytotoxicity as examples. In summary, we present the first LN-mimicking in vitro 3D culture for primary CLL, which enables readouts such as real-time drug screens, kinetic growth assays, and spatial localization. This is the first in vitro CLL system that allows testing of response and resistance to venetoclax and Bruton's tyrosine kinase inhibitors in the context of the tumor microenvironment, thereby opening up new possibilities for clinically useful applications.

摘要

慢性淋巴细胞白血病(CLL)细胞高度依赖于微环境细胞和信号。淋巴结(LN)是体内CLL增殖以及对化疗和靶向药物产生耐药性的关键部位。我们提出了一种新模型,该模型纳入了CLL淋巴结的关键方面,能够在保护性微环境中研究CLL细胞。我们描述了一种三维(3D)体外培养系统,使用超低附着板来创建源自外周血的CLL细胞球体。从在淋巴结样本中观察到的CLL与T细胞比例开始,通过直接刺激和/或经由T细胞间接诱导CLL激活。与二维培养相比,3D培养以T细胞依赖的方式促进CLL增殖,并能够扩增长达7周,包括在培养数周后形成滤泡样结构。该模型能够进行高通量药物筛选,我们以对布鲁顿酪氨酸激酶(Btk)抑制的反应、维奈托克耐药性和T细胞介导的细胞毒性为例进行了描述。总之,我们展示了首个用于原发性CLL的模拟淋巴结的体外3D培养,它能够实现实时药物筛选、动力学生长测定和空间定位等检测。这是首个体外CLL系统,能够在肿瘤微环境背景下测试对维奈托克和布鲁顿酪氨酸激酶抑制剂的反应及耐药性,从而为临床有用的应用开辟了新的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/7f496b38de36/hs9-7-e938-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/9cc7ce05237f/hs9-7-e938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/3c6071141ed4/hs9-7-e938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/f8bdd6020168/hs9-7-e938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/34ab51ab239f/hs9-7-e938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/9d0fb43fc9c0/hs9-7-e938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/7f496b38de36/hs9-7-e938-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/9cc7ce05237f/hs9-7-e938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/3c6071141ed4/hs9-7-e938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/f8bdd6020168/hs9-7-e938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/34ab51ab239f/hs9-7-e938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/9d0fb43fc9c0/hs9-7-e938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/680b/10448932/7f496b38de36/hs9-7-e938-g006.jpg

相似文献

1
In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival.体外3D球体培养系统显示慢性淋巴细胞白血病在T细胞依赖性作用下持续增殖和存活。
Hemasphere. 2023 Aug 23;7(9):e938. doi: 10.1097/HS9.0000000000000938. eCollection 2023 Sep.
2
BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.BCL-2 抑制作为慢性淋巴细胞白血病的治疗方法。
Curr Treat Options Oncol. 2021 Jun 10;22(8):66. doi: 10.1007/s11864-021-00862-z.
3
Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.布鲁顿酪氨酸激酶抑制剂可抑制慢性淋巴细胞白血病中 FcγRIIA 介导的血小板对细菌的反应。
Front Immunol. 2021 Nov 29;12:766272. doi: 10.3389/fimmu.2021.766272. eCollection 2021.
4
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting.CD3×CD20 双特异性抗体 epcoritamab 在 CLL 中的细胞毒性可通过同时靶向 BTK 或 BCL-2 而增强。
Blood Adv. 2023 Aug 8;7(15):4089-4101. doi: 10.1182/bloodadvances.2022009517.
5
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.选择性 BTK 抑制可提高苯达莫司汀治疗反应并使慢性淋巴细胞白血病中的免疫效应功能正常化。
Int J Cancer. 2019 Jun 1;144(11):2762-2773. doi: 10.1002/ijc.32010. Epub 2019 Jan 16.
6
Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.布鲁顿酪氨酸激酶抑制增加慢性淋巴细胞白血病对BCL-2的依赖性并增强对维奈托克的敏感性。
Leukemia. 2017 Oct;31(10):2075-2084. doi: 10.1038/leu.2017.32. Epub 2017 Jan 23.
7
Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?慢性淋巴细胞白血病中的增殖信号;我们遗漏了什么?
Front Oncol. 2020 Oct 8;10:592205. doi: 10.3389/fonc.2020.592205. eCollection 2020.
8
Noncatalytic Bruton's tyrosine kinase activates PLCγ variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells.非催化性布鲁顿酪氨酸激酶激活 PLCγ 变异体,介导伊布替尼耐药的人慢性淋巴细胞白血病细胞。
J Biol Chem. 2020 Apr 24;295(17):5717-5736. doi: 10.1074/jbc.RA119.011946. Epub 2020 Mar 17.
9
Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.淋巴结微环境中的慢性淋巴细胞白血病细胞呈现出与侵袭性疾病相关的分子特征。
Mol Med. 2014 Jul 15;20(1):290-301. doi: 10.2119/molmed.2012.00303.
10
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.CD3xCD19 DART 分子治疗诱导非凋亡性杀伤,并且对高风险化疗和 venetoclax 耐药性慢性淋巴细胞白血病细胞有效。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2019-000218.

引用本文的文献

1
3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia.三维肿瘤微环境相互作用揭示了慢性淋巴细胞白血病中AP-1复合物对骨髓基质细胞的调控及接触介导的重编程。
Hemasphere. 2025 Aug 13;9(8):e70199. doi: 10.1002/hem3.70199. eCollection 2025 Aug.
2
A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia.一种概括淋巴结微环境保护作用并作为慢性淋巴细胞白血病药物测试平台的球体模型。
Hemasphere. 2025 Jul 7;9(7):e70170. doi: 10.1002/hem3.70170. eCollection 2025 Jul.
3

本文引用的文献

1
RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model.RGDS 修饰的超多孔聚(2-羟乙基甲基丙烯酸酯)支架作为 3D 体外白血病模型。
Int J Mol Sci. 2021 Feb 27;22(5):2376. doi: 10.3390/ijms22052376.
2
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.TLR9 在慢性淋巴细胞白血病中的表达鉴定出一个促迁移亚群和新的治疗靶点。
Blood. 2021 Jun 3;137(22):3064-3078. doi: 10.1182/blood.2020005964.
3
Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?
A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation.
时间问题:微环境相互作用如何塑造慢性淋巴细胞白血病和Richter转化对免疫疗法的反应
Front Immunol. 2025 May 29;16:1592574. doi: 10.3389/fimmu.2025.1592574. eCollection 2025.
4
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.组成型CXCR4寡聚体的破坏会损害淋巴瘤的致癌特性。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2424186122. doi: 10.1073/pnas.2424186122. Epub 2025 Jun 11.
5
Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia.线粒体代谢对慢性淋巴细胞白血病T细胞功能障碍的影响
Front Cell Dev Biol. 2025 Apr 17;13:1577081. doi: 10.3389/fcell.2025.1577081. eCollection 2025.
6
Interactions between leukemia and feeders in co-cultivation under hypoxia.缺氧条件下共培养体系中白血病细胞与饲养层细胞之间的相互作用。
BMC Cancer. 2025 Apr 14;25(1):678. doi: 10.1186/s12885-025-13988-2.
7
Lymphoma-on-chip model reveals that lymph node stromal cells promote diffuse large B-cell lymphoma survival and migration.芯片上的淋巴瘤模型表明,淋巴结基质细胞可促进弥漫性大B细胞淋巴瘤的存活和迁移。
Mater Today Bio. 2025 Feb 7;31:101544. doi: 10.1016/j.mtbio.2025.101544. eCollection 2025 Apr.
8
culture of leukemic cells in collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel.白血病细胞在胶原蛋白支架和羧甲基纤维素-聚乙二醇凝胶中的培养
PeerJ. 2024 Dec 6;12:e18637. doi: 10.7717/peerj.18637. eCollection 2024.
9
An overview of immunotoxicity in drug discovery and development.药物发现与开发中的免疫毒性概述。
Toxicol Lett. 2025 Jan;403:66-75. doi: 10.1016/j.toxlet.2024.11.007. Epub 2024 Nov 25.
10
Spheroid culture to select theoretical therapeutic drugs in intravascular large B-cell lymphoma.用于选择血管内大B细胞淋巴瘤理论治疗药物的球体培养
Cancer Sci. 2025 Jan;116(1):214-225. doi: 10.1111/cas.16310. Epub 2024 Oct 20.
慢性淋巴细胞白血病中的增殖信号;我们遗漏了什么?
Front Oncol. 2020 Oct 8;10:592205. doi: 10.3389/fonc.2020.592205. eCollection 2020.
4
Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents.慢性淋巴细胞白血病骨髓微环境的三维共培养模型可预测患者对动员剂的特异性反应。
Haematologica. 2021 Sep 1;106(9):2334-2344. doi: 10.3324/haematol.2020.248112.
5
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL.伊布替尼或 venetoclax 治疗后 Bcl-2 家族成员的变化揭示了决定 CLL 对 venetoclax 耐药性的功能层次。
Blood. 2020 Dec 17;136(25):2918-2926. doi: 10.1182/blood.2019004326.
6
Clonal dynamics in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的克隆动力学。
Blood Adv. 2019 Nov 26;3(22):3759-3769. doi: 10.1182/bloodadvances.2019000367.
7
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment.慢性淋巴细胞白血病患者的淋巴结和外周血中的免疫组成在 venetoclax 治疗期间发生改变。
Blood Adv. 2019 Sep 10;3(17):2642-2652. doi: 10.1182/bloodadvances.2019000360.
8
Constitutive Activation of the B Cell Receptor Underlies Dysfunctional Signaling in Chronic Lymphocytic Leukemia.B 细胞受体的组成性激活是慢性淋巴细胞白血病信号转导功能障碍的基础。
Cell Rep. 2019 Jul 23;28(4):923-937.e3. doi: 10.1016/j.celrep.2019.06.069.
9
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo.BCR 相关因子驱动慢性淋巴细胞白血病细胞体外增殖。
Sci Rep. 2019 Jan 24;9(1):701. doi: 10.1038/s41598-018-36853-8.
10
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib.TLR 信号在淋巴结驻留的 CLL 细胞中被激活,ibrutinib 只能部分抑制其活性。
Cancer Res. 2019 Jan 15;79(2):360-371. doi: 10.1158/0008-5472.CAN-18-0781. Epub 2018 Nov 29.